Eric Larsen has over 25 years of business, investment, and technology project management experience. Mr. Larsen served as Entrepreneur in Residence for Life Sciences with the University of Washington’s CoMotion office advising prospective spinout teams on technology and fundraising strategy. An experienced entrepreneur, Larsen has worked with emerging Northwest companies seeking to scale by leveraging his broad experience in engineering, technology, finance, and business operations. Mr. Larsen currently acts as the CEO of SiDx Inc., serves on the board of 2morrow Health, and he is a board observer and advisor to the CEO of Cyrus Biotech.

Previously as a partner at Quellos Mr. Larsen developed processes and technology to scale Quellos’s business from 17 employees with $324 million in assets, to 350 employees with $25 billion in assets prior to the sale to BlackRock. As a Managing Director at BlackRock Mr. Larsen ran global technology development and implementation projects.